VTWOvsXBI

Vanguard Russell 2000 ETF or State Street SPDR S&P Biotech ETF, side by side from their own SEC filings. 7.2% of their stock holdings are the same at the same weight, across 105 stocks in both. VTWO costs 0.06% a year against 0.35% for XBI, $29 a year less on $10,000. Over the last twelve months VTWO returned +43.2% and XBI +91.7%.

7.2%of the two portfolios is the same stocks at the same weight
VTWO7.2% in stocks the other holds too
XBI68% in stocks the other holds too
stocks in bothstocks only in that fundbonds, cash and unmatched shares

The two funds

From each fund's latest N-PORT filing and its prospectus.

VTWOXBIYearly cost0.06%0.35%Net assets$17.5B$10.7BPositions1,957161Last 12 months+43.2%+91.7%3 years, a year+20.3%+24.1%5 years, a year+6.7%+3.3%Largest holdingVanguard 2.4%State 5.9%Main sectorTechnology 18%Healthcare 94%Holdings as ofMay 31, 2026Jun 30, 2026

Returns are total returns with dividends reinvested, from the funds’ own monthly figures; “(price)” marks a fund whose filing record is younger than a year, whose twelve months are its price change. The stronger figure in each row is set in bold. Past returns say what happened, not what will.

Growth of $100

Both funds from September 2019, the first month both report, dividends reinvested.

VTWO$215XBI$171
September 2019May 2026

More comparisons

From each fund’s Form N-PORT (VTWO: May 2026, XBI: June 2026) and prospectus, via the SEC’s public data sets. Overlap counts only the stocks we can match to a listing: stock by stock, the smaller of the two weights, added up.